Pharmaceutical Social network has the ability to provide one-stop service
Pharmaceutical Social network has the ability to provide one-stop service
According to foreign media reports, just recently, Google, Yahoo, Microsoft and AOL Time Warner arm of the four drugs research Social network company, or never seemed to dominate the drugs R&D traffic and advertising revenue of the industry giants. Overall, these four companies dominate the clinical research blog advertising revenue nearly 90% of the total.
But now the company's dominance of the four will face challenges. In this case is not a drag on economic downturn, the growth of four companies, nor is the company itself or between the four major reasons. Last year, Yahoo indeed been eventful: the Microsoft acquisition between the fierce battle with the anti-takeover battle in full swing, that later Carl Icahn inhalation Yahoo board and Yang emperor to abdicate. AOL or so, its former CEO Jonathan Miller put it bluntly, AOL in social media missed an opportunity. Microsoft bought Yahoo fail, and continue to challenge Google in the search for effective ways to search advertising position, but the efforts have not been returned.
In addition to the four factors that the company itself, they also faced an even greater threat, that is, Pharmaceutical Social network. Today's Pharmaceutical Social network is growing faster than staggering, has become a network of networks, and equipped with four companies provide one-stop services.
Recent Entries
- Osteoporosis Classification
- Penile implants Risk Analysis,scar Spongiform,CRO Pharmaceutical Contract Research
- The use of Pharmaceutical Social network marketing
- Pharmaceutical Social network influence in creating the Pharmaceutical
- In the Pharmaceutical Social network of one-stop Pharmaceutical sevise
- Pharmaceutical Social network has the ability to provide one-stop service
- E-mail promoting the development of Pharmaceutical Social network
- Pharmaceutical Social network closure is the biggest problem
- Future Pharmaceutical Social network
- Difficult for the commercialization of Pharmaceutical Social network